Proto Script Pharmaceutical Corp.
PSCR · OTC
9/30/2017 | 6/30/2017 | 3/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $9 | $88 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $2 | $9 | $88 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 120.3% | -17.3% | 37.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 84.8% | 26.3% | 77.6% | 0.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -64.9% | -184.8% | -66.7% | -376.7% |
| Net Income | -$0 | -$0 | -$1 | -$7 |
| % Margin | -112.6% | -290.8% | -365.8% | -7,238.9% |
| EPS Diluted | -0.006 | -0.007 | -0.003 | -0.077 |
| % Growth | 14.7% | -100% | 95.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |